Healthcare provider profile · identity verified

Corrina Cain

Nurse Practitioner · CRAWFORDSVILLE, IN · NPI 1457707614

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1119	322
Levothyroxine Sodium	Levothyroxine Sodium	624	167
Amlodipine Besylate	Amlodipine Besylate	498	142
Lisinopril	Lisinopril	496	152
Losartan Potassium	Losartan Potassium	377	111
Metoprolol Succinate	Metoprolol Succinate	367	102
Gabapentin	Gabapentin	364	102
Omeprazole	Omeprazole	314	91
Metformin Hcl	Metformin Hcl	267	72
Pantoprazole Sodium	Pantoprazole Sodium	246	81
Escitalopram Oxalate	Escitalopram Oxalate	233	63
Hydrochlorothiazide	Hydrochlorothiazide	230	63
Trazodone Hcl	Trazodone Hcl	210	66
Buspirone Hcl	Buspirone Hcl	209	60
Tamsulosin Hcl	Tamsulosin Hcl	206	59
Alendronate Sodium	Alendronate Sodium	179	50
Metoprolol Tartrate	Metoprolol Tartrate	169	46
Albuterol Sulfate Hfa	Albuterol Sulfate	167	67
Furosemide	Furosemide	163	58
Glimepiride	Glimepiride	162	49
Sertraline Hcl	Sertraline Hcl	154	52
Pravastatin Sodium	Pravastatin Sodium	151	50
Spironolactone	Spironolactone	143	42
Eliquis	Apixaban	130	36
Fluticasone Propionate	Fluticasone Propionate	127	46
Metformin Hcl Er	Metformin Hcl	125	35
Allopurinol	Allopurinol	120	34
Famotidine	Famotidine	107	34
Fluoxetine Hcl	Fluoxetine Hcl	104	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	27
Montelukast Sodium	Montelukast Sodium	100	32
Clopidogrel	Clopidogrel Bisulfate	99	32
Rosuvastatin Calcium	Rosuvastatin Calcium	99	34
Simvastatin	Simvastatin	99	25
Carvedilol	Carvedilol	95	31
Duloxetine Hcl	Duloxetine Hcl	93	24
Bupropion Xl	Bupropion Hcl	90	23
Potassium Chloride	Potassium Chloride	90	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	26
Ozempic	Semaglutide	79	20
Zolpidem Tartrate	Zolpidem Tartrate	76	12
Donepezil Hcl	Donepezil Hcl	73	29
Mounjaro	Tirzepatide	73	14
Oxybutynin Chloride Er	Oxybutynin Chloride	69	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	68	48
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	19
Ezetimibe	Ezetimibe	64	23
Tizanidine Hcl	Tizanidine Hcl	64	35
Jardiance	Empagliflozin	63	16
Prednisone	Prednisone	62	47
Meloxicam	Meloxicam	61	15
Atenolol	Atenolol	56	15
Doxycycline Hyclate	Doxycycline Hyclate	53	39
Tramadol Hcl	Tramadol Hcl	53	13
Citalopram Hbr	Citalopram Hydrobromide	52	15
Amitriptyline Hcl	Amitriptyline Hcl	51	15
Cephalexin	Cephalexin	49	35
Pioglitazone Hcl	Pioglitazone Hcl	49	15
Venlafaxine Hcl Er	Venlafaxine Hcl	49	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	48	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	11
Januvia	Sitagliptin Phosphate	40	12
Dicyclomine Hcl	Dicyclomine Hcl	39	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Meclizine Hcl	Meclizine Hcl	37	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	14
Synthroid	Levothyroxine Sodium	37	suppressed
Celecoxib	Celecoxib	36	14
Fenofibrate	Fenofibrate Nanocrystallized	36	12
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	11
Varenicline Tartrate	Varenicline Tartrate	34	13
Azithromycin	Azithromycin	33	27
Naproxen	Naproxen	33	15
Levetiracetam	Levetiracetam	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	28
Lovastatin	Lovastatin	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Glipizide	Glipizide	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Fluconazole	Fluconazole	17	14
Glipizide Er	Glipizide	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Ramipril	Ramipril	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Risperidone	Risperidone	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Topiramate	Topiramate	15	suppressed
Valsartan	Valsartan	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Torsemide	Torsemide	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Tegretol	Carbamazepine	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nystatin	Nystatin	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Diazepam	Diazepam	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error